Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Trends in Immunology|April 17, 2026
Exploiting immunogenic cell death to promote antitumor immunityGabriele Casagrande Raffi, Siying Wang, Liqin Wang, et al.Plos One|October 8, 2011
The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescenceJeroen H Nijwening, Ernst-Jan Geutjes, Rene Bernards, et al.Breast Cancer Research and Treatment|August 6, 2013
Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnosticsFloris H Groenendijk, Wilbert Zwart, Arno Floore, et al.British Journal of Cancer|November 18, 2020
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisibSanne C F A Huijberts, Mirjam C Boelens, Rene Bernards, et al.Future Oncology (London, England)|February 7, 2020
Encorafenib, binimetinib and cetuximab combined therapy for patients with BRAFV600E mutant metastatic colorectal cancerSanne Cfa Huijberts, Robin Mjm van Geel, Rene Bernards, et al.Trends in Molecular Medicine|August 4, 2018
An Experimenter's Guide to Glioblastoma Invasion PathwaysMark C de Gooijer, Miriam Guillén Navarro, Rene Bernards, et al.Nature Biotechnology|April 26, 2016
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genesBastiaan Evers, Katarzyna Jastrzebski, Jeroen P M Heijmans, et al.Nature Protocols|October 8, 2025
Inducible CRISPR-Cas9 screening platform to interrogate non-proliferative cellular statesGabriele Casagrande Raffi, Hendrik J Kuiken, Cor Lieftink, et al.Journal of Cellular and Molecular Medicine|January 4, 2012
Identification of F-box only protein 7 as a negative regulator of NF-kappaB signallingHendrik J Kuiken, David A Egan, Heike Laman, et al.Biomarker Insights|December 15, 2010
Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancerSun Tian, Paul Roepman, Laura J Van't Veer, et al.Pageof 8